Home Occlutech

Occlutech

Occlutech Announces Atrial Flow Regulator Has Received U.S. FDA Breakthrough Device Designation for Heart Failure

The AFR is for use in patients with Heart Failure with Preserved Ejection Fraction (HFpEF) or Reduced Ejection Fraction (HFrEF) and who, despite optimal medical therapy, experience worsening symptoms.